 |
 |
|
|
RESÚMENES ENERO 2009 |
Other Neuropsychiatric Disorders & General Information
(Haga un click en la
información del journal para acceder al resúmen)
5 – doble-ciego o
metanálisis; 4 – subanálisis o simple ciego; 3 –
revisión, abierto, básico; 2 – casos; 1 – opinión
GRATIS = Texto gratuito en algunos países de la región iberoamericana
(algunos artículos requieren ir a la tabla de contenidos del
número actual de la revista)
3! - Excess
mortality, causes of death and prognostic factors in anorexia nervosa
Fotios C Papadopoulos, Anders Ekbom,
The British Journal of Psychiatry (2009) 194:
10-17
5 - Childhood
abuse and treatment response in patients with irritable bowel syndrome: a post-hoc analysis
of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release
C. Han, P.
S. Masand, S. Krulewicz, K. Peindl, P. Mannelli, I. M. Varia, C.-U. Pae and A. A. Patkar
Journal of Clinical Pharmacy and Therapeutics. Volume 34 Issue 1, Pages 79 - 88
3! - McLean-Harvard International First-Episode Project:
Two-Year Stability of DSM-IV Diagnoses in 500 First-Episode Psychotic Disorder
Patients
Paola Salvatore, Ross
J. Baldessarini, Mauricio Tohen,
Hari-Mandir K. Khalsa,
Jesus Perez Sanchez-Toledo, Carlos A. Zarate, Jr.,
Eduard Vieta, and Carlo Maggini
J Clin Psychiatry December 30, 2008: e1-e9
3! - The
relationship between migraine and mental disorders in a population-based sample
Gregory E. Ratcliffe,
General Hospital Psychiatry. Volume 31, Issue 1,
January-February 2009, Pages 14-19
3! -
Cause-specific excess mortality in suicidal patients: gender differences in
mortality patterns
Elfi Antretter,
Dirk Dunkel and Christian Haring
General Hospital Psychiatry. Volume 31, Issue 1,
January-February 2009, Pages 67-74
5 - Treatment
of Fibromyalgia Syndrome With Antidepressants. A
Meta-analysis
Winfried Häuser, Kathrin Bernardy, Nurcan Üçeyler, Claudia Sommer
5 - Once-Daily Atomoxetine for
Adult Attention-Deficit/Hyperactivity Disorder: A 6-Month, Double-Blind Trial
Adler, Lenard A; Spencer,
Thomas; Brown, Thomas E; Holdnack, James; Saylor,
Keith; Schuh, Kory; Trzepacz,
Paula T; Williams, David W; Kelsey, Douglas
Journal of Clinical
Psychopharmacology. 29(1):44-50,
February 2009
3! - A meta-analysis of the accuracy of the
mini-mental state examination in the detection of dementia and mild cognitive
impairment
Alex J. Mitchell
Journal of Psychiatric Research. Volume 43, Issue 4, January 2009, Pages 411-431
3 - Cognitive and psychiatric effects of
vitamin B12 replacement in dementia with low serum B12 levels:
a nursing home study
Christopher H. van Dyck, Jeffrey M. Lyness, Robert
M. Rohrbaugh and Alan P. Siegal
International
Psychogeriatrics (2009), 21:138-147
5! - The
dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a
randomised placebo-controlled trial
, for
the DART-AD investigators
The
Lancet Neurology, Volume 8, Issue 2, Pages 151 - 157, February 2009
3 - Memantine: a
comprehensive review of safety and efficacy
Harish Kavirajan
Expert
Opinion on Drug Safety. January 2009, Vol. 8, No. 1, Pages 89-109
3 - The Influence of Postnatal Psychiatric
Disorder on Child Development. Is Maternal Preoccupation One of the Key
Underlying Processes?
Alan Stein, Annukka Lehtonen,
Allison G. Harvey, Rosie Nicol-Harper, Michelle Craske
Psychopathology 2009;42:11-21
3 - Quetiapine
Dosage Across Diagnostic Categories
Yasser Khazaal, Anne Chatton, Riaz Khan and Daniele Zullino
Psychiatric Quarterly. OnLine First. January 14, 2009
4 - Long-Term Safety, Tolerability, and
Efficacy of Duloxetine in the Treatment of
Fibromyalgia
Philip J. Mease, I. Jon Russell, Daniel K. Kajdasz, Curtis G. Wiltse,
Michael J. Detke, Madelaine
M. Wohlreich, Daniel J. Walker and Amy S. Chappell
Seminars
in Arthritis and Rheumatism.
Article in
Press, January 2009
3! - Gender
issues in suicide rates, trends and methods among youths aged 15–24 in 15
European countries
Airi Värnik, Kairi Kõlves, Jüri
Allik, Ella Arensman, Esa Aromaa, Chantal van Audenhove,
Jean-Hervé Bouleau, Christina M. van der Feltz-Cornelis, Giancarlo Giupponi,
Ricardo Gusmão, Maria Kopp, Andrej Marusic, Margaret
Maxwell, Högni Óskarsson,
Ann Palmer, Charles Pull, Anu
Realo, Thomas Reisch, Armin
Schmidtke, Victor Pérez Sola, Lisa Wittenburg and Ulrich Hegerl
Journal of Affective Disorders. Volume 113, Issue 3, March 2009, Pages 216-226
3 - Psychotropic
Medication Nonadherence Among
Nicole
M. Lanouette, David P. Folsom,
Andres Sciolla, and Dilip V. Jeste
Psychiatr Serv 60:157-174, February 2009
3 - Emerging
treatments for premature ejaculation: focus on dapoxetine
Wayne JG Hellstrom
Neuropsychiatric Disease and Treatment. December 2008
5 - A randomised, placebo-controlled, 24-week, study of
low-dose extended-release methylphenidate in adults with
attention-deficit/hyperactivity disorder
Michael Rösler, Roland Fischer,
Richard Ammer, Claudia Ose,
Wolfgang Retz and on behalf of the study group
European Archives of Psychiatry and Clinical Neuroscience. On Line First. January 2009
3! -
Biochemical indicators of vitamin B12 and folate
insufficiency and cognitive decline
Christine C. Tangney, Yuxiao Tang, Denis A. Evans, and Martha Clare Morris
GRATIS 3!
- Atypical antipsychotics fail to improve
functioning or quality of life in people with Alzheimer’s disease
C. Ballard
Evid
Based Ment Health 2009 12: 20
GRATIS 3
- Short term use of antipsychotics increases the
risk of serious adverse events in elderly people with dementia
Eleonora Esposito
Evid Based Ment Health
2009; 12: 23
GRATIS 5 - Dimebon improves cognitive
function in people with mild to moderate Alzheimer’s disease
Serge Gauthier
Evid
Based Ment Health 2009; 12: 21
GRATIS 5
- Varying effects of psychotropic medications on
fracture risk in older people
P. Vestergaard
Evid
Based Ment Health 2009 12: 25
3 - Role of
Antiepileptic Drugs in the Management of Eating Disorders
McElroy, Susan L; Guerdjikova, Anna I;
Martens, Brian; Keck, Paul E. Jr; Pope, Harrison G;
Hudson, James I
CNS Drugs:Volume 23(2)2009pp 139-156
3 - Dopamine
Dysregulation Syndrome: An Overview of its Epidemiology,
Mechanisms and Management
O'Sullivan, Sean S; Evans, Andrew H; Lees, Andrew J
CNS Drugs:Volume 23(2)2009pp 157-170
3! -
Assessing Residual Confounding of the Association between Antipsychotic
Medications and Risk of Death using Survey Data
Schneeweiss, Sebastian; Setoguchi, Soko;
Brookhart, M. Alan; Kaci, Liljana; Wang, Philip S
CNS Drugs:Volume 23(2)2009pp 171-180
3 - Short Onset of Action of a Serotonin
Reuptake Inhibitor When Used to Reduce Premenstrual Irritability
Mikael Landén, Helena Erlandsson,
Finn Bengtsson, Björn Andersch and Elias Eriksson
Neuropsychopharmacology (2009) 34, 585–592
3 - Potential adverse effects of amphetamine
treatment on brain and behavior: a review
S M Berman,
R Kuczenski, J T McCracken and E D
Molecular
Psychiatry
(2009) 14, 123–142
GRATIS 3
- DNA Microarray
Technology in the Clinical Environment: The AmpliChip
CYP450 Test for CYP2D6 and CYP2C19 Genotyping
Jose de Leon, Margaret T. Susce, Maria
Johnson, Mike Hardin, Lorraine Maw, Alison Shao, Antonette C.P. Allen, Francis A. Chiafari,
Grantland Hillman, and D. Michele Nikoloff
3 - Cholesterol in
Alzheimer’s Disease: Unresolved Questions
Massimo
Stefani and Gianfranco Liguri
Current Alzheimer Research. Volume 6, Number 1, February 2009
3 - Different Cholinesterase Inhibitor Effects on CSF Cholinesterases
in Alzheimer Patients
Agneta Nordberg, Taher Darreh-Shori, Elaine Peskind, Hilkka Soininen, Malahat Mousavi, Gina Eagle and Roger
Lane
Current Alzheimer Research. Volume 6, Number 1, February 2009
GRATIS 3
- Behavioral Management
for Anorexia Nervosa
Evelyn Attia, and B. Timothy Walsh
NEJM. Volume
360:500-506; January 29, 2009, Number
5
GRATIS 3 - Valeriana en el
tratamiento a largo plazo del insomnio
Oscar Medina Ortiz,
Nora Sánchez-Mora, David Fraguas Herraez, Celso Arango López
Rev Col
Psiquiatria. Volumen 37 Nº 4 Diciembre 2008
| Regresar a RESÚMENES ENERO 2009 |